{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:42:15Z","timestamp":1789735335875,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"James and Esther King Research Program Florida Department of Health","award":["08KN-01"],"award-info":[{"award-number":["08KN-01"]}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["GM101225"],"award-info":[{"award-number":["GM101225"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009282","name":"United Mitochondrial Disease Foundation","doi-asserted-by":"crossref","award":["14050R"],"award-info":[{"award-number":["14050R"]}],"id":[{"id":"10.13039\/100009282","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.mito.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T01:34:41Z","timestamp":1422495281000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies"],"prefix":"10.1016","volume":"23","author":[{"given":"Susana","family":"Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Torraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Iommarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2015.01.007_bb0005","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1212\/01.WNL.0000056088.09408.3C","article-title":"Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO)","volume":"60","author":"Agostino","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2015.01.007_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cmet.2011.11.012","article-title":"Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice","volume":"15","author":"Ahlqvist","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0015","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/hmg\/ddq076","article-title":"Ketogenic diet slows down mitochondrial myopathy progression in mice","volume":"19","author":"Ahola-Erkkil\u00e4","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0020","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/hmg\/ddn143","article-title":"Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance","volume":"17","author":"Akman","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4023","article-title":"Pharmacological approaches to restore mitochondrial function","volume":"12","author":"Andreux","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mito.2015.01.007_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mito.2015.01.007_bb0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/sj.gt.3302981","article-title":"Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a \u2018differential multiple cleavage-site\u2019 model","volume":"14","author":"Bacman","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/gt.2010.25","article-title":"Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease","volume":"17","author":"Bacman","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/gt.2011.196","article-title":"Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease","volume":"19","author":"Bacman","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0050","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","article-title":"Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs","volume":"19","author":"Bacman","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0060","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2007-1701","article-title":"Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components","volume":"93","author":"Bastin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0065","doi-asserted-by":"crossref","first-page":"14392","DOI":"10.1073\/pnas.0502896102","article-title":"Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease","volume":"102","author":"Bayona-Bafaluy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1139\/H08-074","article-title":"PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions","volume":"33","author":"Benton","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1056\/NEJMc0806334","article-title":"Bezafibrate for an inborn mitochondrial beta-oxidation defect","volume":"360","author":"Bonnefont","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/mt.2013.230","article-title":"AAV-mediated liver-specific MPV17 expression restores mtDNA levels and prevents diet-induced liver failure","volume":"22","author":"Bottani","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/brain\/awr290","article-title":"Downregulation of apoptosis-inducing factor in Harlequin mice induces progressive and severe optic atrophy which is durably prevented by AAV2-AIF1 gene therapy","volume":"135","author":"Bouaita","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.mito.2015.01.007_bb0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10637-012-9922-7","article-title":"Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery","volume":"31","author":"Bundred","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.mito.2015.01.007_bb0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Canto","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0100","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2014.04.001","article-title":"NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease","volume":"19","author":"Cerutti","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1474-9726.2010.00581.x","article-title":"Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria","volume":"9","author":"Dai","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.mito.2015.01.007_bb0110","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/emmm.201201433","article-title":"Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy","volume":"4","author":"Di Meo","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0115","doi-asserted-by":"crossref","first-page":"e44335","DOI":"10.1371\/journal.pone.0044335","article-title":"Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse","volume":"7","author":"Dillon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2015.01.007_bb0120","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/hmg\/dds049","article-title":"Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse","volume":"21","author":"Dillon","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cmet.2011.11.003","article-title":"Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders","volume":"14","author":"Djouadi","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0130","doi-asserted-by":"crossref","first-page":"e1003182","DOI":"10.1371\/journal.pgen.1003182","article-title":"Alternative oxidase expression in the mouse enables bypassing cytochrome c oxidase blockade and limits mitochondrial ROS overproduction","volume":"9","author":"El-Khoury","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0135","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/bph.12570","article-title":"Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives","volume":"171","author":"El-Khoury","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mito.2015.01.007_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cmet.2009.03.004","article-title":"Expression of the Ciona intestinalis alternative oxidase (AOX) in Drosophila complements defects in mitochondrial oxidative phosphorylation","volume":"9","author":"Fernandez-Ayala","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.gt.3302443","article-title":"Adeno-associated virus-mediated gene transfer of the heart\/muscle adenine nucleotide translocator (ANT) in mouse","volume":"12","author":"Flierl","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20091372","article-title":"Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP","volume":"426","author":"Fogarty","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.mito.2015.01.007_bb0160","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15252\/emmm.201404092","article-title":"Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency","volume":"6","author":"Garone","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy","volume":"52","author":"Guy","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2015.01.007_bb0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mito.2015.01.007_bb0180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1081\/NCN-200027485","article-title":"Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder","volume":"23","author":"Hirano","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.mito.2015.01.007_bb0175","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbagen.2012.01.006","article-title":"CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders","volume":"1820","author":"Hirano","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2015.01.007_bb0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mito.2015.01.007_bb0190","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha","volume":"104","author":"Jager","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng0597-93","article-title":"Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice","volume":"16","author":"Jenuth","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature11861","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"493","author":"Johnson","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mito.2015.01.007_bb0205","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mito.2015.01.007_bb0210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbabio.2009.07.006","article-title":"A novel functional element in the N-terminal region of Arum concinnatum alternative oxidase is indispensable for catalytic activity of the enzyme in HeLa cells","volume":"1797","author":"Kakizaki","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2015.01.007_bb0215","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/hmg\/ddr200","article-title":"adPEO mutations in ANT1 impair ADP\u2013ATP translocation in muscle mitochondria","volume":"20","author":"Kawamata","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","article-title":"Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3","volume":"6","author":"Khan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","article-title":"Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging","volume":"309","author":"Kujoth","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mito.2015.01.007_bb0230","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/hmg\/ddn401","article-title":"Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice","volume":"18","author":"Lopez","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0235","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.bbrc.2004.05.104","article-title":"Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A","volume":"319","author":"Mott","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mito.2015.01.007_bb0240","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1093\/brain\/awn252","article-title":"Resistance training in patients with single, large-scale deletions of mitochondrial DNA","volume":"131","author":"Murphy","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.mito.2015.01.007_bb0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2008.06.051","article-title":"AMPK and PPARdelta agonists are exercise mimetics","volume":"134","author":"Narkar","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mito.2015.01.007_bb0250","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.mito.2012.12.003","article-title":"Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy","volume":"13","author":"Noe","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2015.01.007_bb0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1079\/PNS2004339","article-title":"Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle","volume":"63","author":"Ojuka","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.mito.2015.01.007_bb0260","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/nar\/gkq769","article-title":"Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task?","volume":"39","author":"Perales-Clemente","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mito.2015.01.007_bb0265","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0270","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","article-title":"New treatments for mitochondrial disease-no time to drop our standards","volume":"9","author":"Pfeffer","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mito.2015.01.007_bb0275","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"19","author":"Pirinen","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0280","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.1006214107","article-title":"Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome","volume":"107","author":"Quintana","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0285","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1172\/JCI62923","article-title":"Fatal breathing dysfunction in a mouse model of Leigh syndrome","volume":"122","author":"Quintana","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mito.2015.01.007_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jmg.2007.052076","article-title":"Isolated cytochrome c oxidase deficiency as a cause of MELAS","volume":"45","author":"Rossmanith","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ymgme.2011.07.016","article-title":"The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases","volume":"104","author":"Saada","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0300","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1073\/pnas.1019581108","article-title":"Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice","volume":"108","author":"Safdar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0305","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.nbd.2011.02.016","article-title":"Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model","volume":"42","author":"Sandi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mito.2015.01.007_bb0310","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.20240","article-title":"Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells","volume":"56","author":"Santra","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2015.01.007_bb0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1196\/annals.1427.006","article-title":"Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator","volume":"1147","author":"Scarpulla","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mito.2015.01.007_bb0320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2004.09.005","article-title":"The epidemiology of mitochondrial disorders\u2014past, present and future","volume":"1659","author":"Schaefer","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2015.01.007_bb0325","doi-asserted-by":"crossref","first-page":"e28823","DOI":"10.1371\/journal.pone.0028823","article-title":"Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice","volume":"6","author":"Schiff","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2015.01.007_bb0330","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/acel.12130","article-title":"Molecular mechanisms underlying genotype-dependent responses to dietary restriction","volume":"12","author":"Schleit","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.mito.2015.01.007_bb0340","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.molmed.2010.04.007","article-title":"Therapeutic prospects for mitochondrial disease","volume":"16","author":"Schon","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0335","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrg3275","article-title":"Human mitochondrial DNA: roles of inherited and somatic mutations","volume":"13","author":"Schon","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0345","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/hmg\/ddp093","article-title":"PGC-1alpha\/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders","volume":"18","author":"Srivastava","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0355","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.1050","article-title":"Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects","volume":"50","author":"Taivassalo","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2015.01.007_bb0350","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/brain\/awl282","article-title":"Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions","volume":"129","author":"Taivassalo","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.mito.2015.01.007_bb0360","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","article-title":"Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome","volume":"165","author":"Tenenbaum","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mito.2015.01.007_bb0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajmg.1380","article-title":"Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options","volume":"106","author":"Thorburn","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0370","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/gt.2011.24","article-title":"Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE","volume":"18","author":"Torres-Torronteras","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0375","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/mt.2014.6","article-title":"Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE","volume":"22","author":"Torres-Torronteras","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mito.2015.01.007_bb0380","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.mito.2015.01.007_bb0385","doi-asserted-by":"crossref","first-page":"17687","DOI":"10.1073\/pnas.0505551102","article-title":"Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice","volume":"102","author":"Tyynismaa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0390","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","article-title":"In vivo correction of COX deficiency by activation of the AMPK\/PGC-1\u03b1 axis","volume":"14","author":"Viscomi","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mito.2015.01.007_bb0400","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","article-title":"Activation of the PPAR\/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype","volume":"8","author":"Wenz","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0405","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1073\/pnas.0911570106","article-title":"Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging","volume":"106","author":"Wenz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0410","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2010.11.012","article-title":"The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimers","volume":"12","author":"Williams","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2015.01.007_bb0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.1071163","article-title":"Regulation of mitochondrial biogenesis in skeletal muscle by CaMK","volume":"296","author":"Wu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.mito.2015.01.007_bb0420","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/hmg\/ddr482","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice","volume":"21","author":"Yatsuga","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2015.01.007_bb0425","doi-asserted-by":"crossref","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2015.01.007_bb0430","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/brain\/awh259","article-title":"Mitochondrial disorders","volume":"127","author":"Zeviani","year":"2004","journal-title":"Brain"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724915000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724915000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T22:17:38Z","timestamp":1589494658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724915000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":86,"alternative-id":["S1567724915000185"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2015.01.007","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}